Quality-of-Life Effects of Prostate-Specific Antigen Screening | Zendy

Eveline A.M. Heijnsdijk | Zendy; Elisabeth M. Wever | Zendy; Anssi Auvinen | Zendy; Jonas Hugosson | Zendy; Stefano Ciatto | Zendy; Vera Nelen | Zendy; Maciej Kwiatkowski | Zendy; Arnauld Villers | Zendy; Álvaro Páez | Zendy; Sue Moss | Zendy; Marco Zappa | Zendy; Teuvo L.J. Tammela | Zendy; Tuukka Mäkinen | Zendy; Sigrid Carlsson | Zendy; Ida J. Korfage | Zendy; MarieLouise EssinkBot | Zendy; Suzie J. Otto | Zendy; Gerrit Draisma | Zendy; Chris H. Bangma | Zendy; Monique J. Roobol | Zendy; Fritz H. Schröder | Zendy; Harry J. de Koning | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality-of-Life Effects of Prostate-Specific Antigen Screening

Author(s) -

Eveline A.M. Heijnsdijk,

Elisabeth M. Wever,

Anssi Auvinen,

Jonas Hugosson,

Stefano Ciatto,

Vera Nelen,

Maciej Kwiatkowski,

Arnauld Villers,

Álvaro Páez,

Sue Moss,

Marco Zappa,

Teuvo L.J. Tammela,

Tuukka Mäkinen,

Sigrid Carlsson,

Ida J. Korfage,

MarieLouise EssinkBot,

Suzie J. Otto,

Gerrit Draisma,

Chris H. Bangma,

Monique J. Roobol,

Fritz H. Schröder,

Harry J. de Koning

Publication year - 2012

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1201637

Subject(s) - overdiagnosis , medicine , prostate cancer , prostate specific antigen , quality of life (healthcare) , prostate , prostate cancer screening , oncology , gynecology , randomized controlled trial , cancer , urology , nursing

After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research